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Secretion of Insulin During Aging 
Richard C. Adelman, PhD 
ecognition of and response to environmental 
challenge are expressed in part by the avail- 
ability and efficacy of circulating hormones for R the modulation of intermediary metabolism in 
target cells. One example of such adaptive capability 
that changes during aging is the impact of dietary glu- 
cose on its insulin-sensitive metabolism by liver and 
peripheral tissues. This paper provides a critical review 
of published research that addresses the pivotal role of 
insulin secretion in that adaptive sequence during aging. 
According to most, but not all, published reports, the 
regulation of insulin secretion by glucose changes dur- 
ing aging. However, interpretation of these data is com- 
plicated by numerous factors, most prominent of which 
include 1) the extent to which it is possible to evaluate 
insulin secretion in vivo by measurement of hormone 
levels in peripheral blood; 2) the distribution of func- 
tionally heterogeneous populations of pancreatic islets 
of Langerhans; 3) distinctions between growth, obesity, 
and aging; and 4) the frequent failure to acknowledge 
relevant, previously published literature. The present 
paper will examine these data both in the context of such 
complications and from the perspective of the pursuit of 
further insight into the fundamental biological pro- 
cesses of aging that are expressed in the absence of dis- 
ease and inappropriate lifestyle. 
ALTERED RESPONSIVENESS TO GLUCOSE 
IN VIVO 
When the pancreas recognizes and responds to an in- 
creased level of blood glucose, insulin is secreted into 
the portal vein and through it is transported immedi- 
ately to the liver. Within the liver insulin exerts certain of 
its hormonal actions and also is metabolized. The pro- 
portion of insulin molecules that escapes its hepatic me- 
tabolism is distributed throughout the peripheral circu- 
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lation and tissues. Therefore, assessment of insulin 
secretion by the pancreas into the circulation can be 
approximated most accurately in portal vein blood. 
The concentration of insulin in portal vein blood is the 
net result of its secretion into the blood by the pancreas 
and its extraction from the blood by the liver at early 
points during the secretory response, although recircu- 
lation of secreted insulin complicates matters increas- 
ingly with the passage of time. However, the concentra- 
tion of insulin in peripheral blood at any given time 
represents the far more complex net result of its pancre- 
atic secretion, hepatic clearance, uptake and clearance 
through peripheral tissues, recirculation, and disposi- 
tion within the blood. Therefore, consideration of pe- 
ripheral blood insulin levels during aging in the con- 
text of the regulation of insulin secretion is excluded 
from this review, although previous work by Chen et 
al,' for example, is particularly relevant in this re- 
gard. 
The pattern of insulin response to glucose detected in 
portal vein blood of fasted rats during aging is complex. 
Gold et a12 injected an aqueous solution of 450 mg glu- 
cose per 100 g of body weight intragastrically into 
three-day fasted, male Sprague - Dawley rats ranging in 
age from two to 24 months. At two months of age the 
initial phase of a biphasic response to glucose is detect- 
able almost instantaneously and is transient. At 12 and 
24 months of age the initial phase of insulin response 
increases in magnitude and duration relative to that ob- 
served at two months. The second phase of response 
begins approximately 30 minutes subsequent to the glu- 
cose challenge and endures for several hours at two 
months of age. However, its time of onset is progres- 
sively delayed from 30 minutes following glucose chal- 
lenge at two months of age, to three to four hours at 12 
months, and to nearly seven hours at 24 months. Under 
these experimental conditions, aortal blood glucose 
concentration peaks within several minutes at a level of 
approximately 220 mg/100 mL and maintains a plateau 
level of approximately 160 mg/100 mL for at least 
seven hours at all ages tested. 
Interpretation of these data within the context of se- 
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cretory capability is difficult. For example, the hyperin- 
sulinemia associated with the early phase of response by 
older, fasted Sprague-Dawley rats may be a conse- 
quence of obesity. Why such hyperinsulinemia is not 
also expressed during the second phase of response is 
unclear. Possible differences in responsiveness to glu- 
cose in the fed and fasted states were not explored. 
Furthermore, apparently reduced rates of insulin clear- 
ance during aging-' may also contribute to the altered 
pattern of response. There apparently are no published 
data on portal vein insulin response in vivo to stimuli 
other than glucose during aging. 
Efficacy of the insulin molecules secreted into portal 
vein blood in response to administered glucose may di- 
minish indirectly during aging as a consequence of the 
enhanced presence of glucagon, the primary physiolog- 
ical antagonist of insulin action on the liver. The sup- 
pression of glucagon secretion into portal vein blood by 
glucose challenge during fasting is progressively inhib- 
ited as Sprague-Dawley rats aged from two to at least 
24 months.' Circulating levels of glucose in this experi- 
ment were identical to those utilized previously2 to gen- 
erate the portal vein insulin response; approximately 
160 mg/100 mL. Similar observations also were re- 
ported in aging Wistar rats?1° although interpretation 
of these latter measurements is complicated by the as- 
sessment of glucagon concentration in peripheral blood, 
as discussed above. 
The molar ratio of glucagon to insulin in portal vein 
blood may be sufficiently high during the initial hours of 
response to glucose by older fasted rats that the sluggish 
adaptation by hepatic glucokinase observed pre- 
viouslyl* is possible only at delayed times of onset as 
excess glucagon levels diminish. Inhibition of the gluco- 
kinase adaptation by simultaneous treatment of two- 
month-old, fasted rats with glucose and glucagon' sup- 
ports such a notion. Whether or not the simultaneous 
treatment of aging rats with glucose and either antibod- 
ies to glucagon or some pharmacological glucagon- 
blocking agent is capable of overcoming the sluggish- 
ness of the glucokinase adaptation remains to be seen. 
Furthermore, interactions between glucagon and liver 
during aging were not investigated under these experi- 
mental conditions. 
Whether or not intrinsic biological potency of insulin 
molecules secreted in vivo changes during aging is un- 
certain. Proinsulin-like material is reported to accumu- 
late in peripheral blood of aging people.12 However, as 
already discussed above, it is difficult to interpret pe- 
ripheral measurements of insulin in the context of insu- 
lin production. 
ALTERED RESPONSIVENESS TO GLUCOSE 
IN VITRO 
The altered insulin response to glucose in vivo detected 
in portal vein blood of aging, fasted Sprague-Dawley 
rats2 probably reflects, at least in part, a change in the 
pancreatic regulation of the glucose-stimulated secre- 
tion of insulin. However, the specific nature of the insu- 
lin response in vitro, including those reports that profess 
the absence of any impact of aging, is highly dependent 
on the protocol utilized for the in vitro secretory system, 
as well as various physiological characteristics of the 
donor animal. Of those numerous factors that influence 
the observed patterns of insulin secretory response in 
vitro at different donor ages, the most noteworthy in- 
clude physical size of the islets tested and response time 
at which insulin levels are measured. Magnitude and 
time course of insulin response to glucose by islets of 
heterogeneous sizes differ considerably at given donor 
ages.13 Furthermore, the distribution of islet sizes 
changes as donors Consequently, much of the 
published data on glucose-stimulated secretion of insu- 
lin in vitro may require reevaluation. 
The pattern of glucose-stimulated insulin response 
detected in vivo by Gold et a12 in portal vein blood of 
fasted, male Sprague-Dawley rats aged two to 24 
months is expressed in part in vitro when insulin secre- 
tion is stimulated by perifusion of isolated islets of dif- 
ferent sizes from corresponding donor rats, as described 
by Kitahara and Adelman.13 The insulin secretory re- 
sponse to 16.7 mmol(300 mg/100 mL) glucose by peri- 
fused small (50 - 80 pm diameter) islets from fasted 
two-month-old rats is delayed by approximately two 
hours when assessing the identical islet population from 
fasted 24-month-old rats. This delayed time of onset 
resembles that observed in vivo for the second phase of 
insulin response in portal vein blood.2 In contrast, the 
insulin secretory response by perifused large (350 - 
400 pm diameter) islets from fasted two-month-old rats 
is several times greater than that of small islets, and is 
only very slightly inhibited, but not altered in time 
course, as donor rats age from two to 24 months. 
The greater prevalence of large islets in the pancreas 
of older rats14-18 may account for the continued ability 
of the pancreas in fasted, 24-month-old rats to secrete 
insulin in vivo into portal vein blood rapidly in response 
to a glucose challenge, a capability that deteriorates in 
small islets in vitro as donor rats age. Perhaps the larger 
islets also contribute to the hyperinsulinemia of first- 
phase insulin response to glucose in vivo at 12 and 24 
months of age. The change in distribution of heteroge- 
neous islet populations during aging is not understood. 
Whether or not the greater prevalence of large islets in 
the pancreas of aging rats represents compensatory islet 
hypertrophy in response to the impaired capability of 
smaller islets for glucose-stimulated secretion of insulin, 
as already ~peculated,'~J~ awaits experimental evi- 
dence. 
Reaven et all9 reported that the magnitude of a glu- 
cose-stimulated (25 mmol; 450 mg/lOO mL) insulin re- 
sponse by an islet incubation system diminishes pro- 
gressively as donor Sprague- Dawley rats age from two 
to 18 months, whereas the number of islet beta cells and 
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islet insulin content increases. This study selected islets 
from a size (diameter) range of 200-400 pm, and the 
islet population examined from progressively older rat 
donors contains progressively larger islets than does the 
islet population examined from younger rat donors. 
Furthermore, insulin response was measured only at the 
60-minute time-point following incubation of islets 
with the stirnulatory concentration of glucose. 
The apparent reduction of insulin responsiveness 
during aging under these conditions is probably the 
consequence of a complex change in distribution of 
functionally distinct islet populations. The secretory 
contribution by the population of small (50-80 pm di- 
ameter) islets described by Kitahara and Adelman,13 
which has a time of onset delayed beyond the utilized 
60-minute incubation period during aging, is apparently 
not included in this study. Whether or not the secretory 
contribution by some proportion of the smaller of those 
islets selected by Reaven et all9 is progressively dimin- 
ished in a similar fashion as donor rats age is uncertain. 
The secretory contribution by larger islets, prevalence of 
which increases during aging, is progressively enhanced 
during aging. Therefore, the number of islet beta cells 
and islet insulin content are increasing in an islet popu- 
lation that is distinctly different than the population that 
is losing insulin responsiveness most prominently (the 
smaller islets) as donor rats grow older. The identical 
issues surrounding heterogeneity of islet size also ob- 
fuscate interpretation of another report by Reaven et alZ0 
that pancreatic regional differences cannot explain the 
reduction in glucose-stimulated insulin response in vitro 
by incubated islets as donor Sprague-Dawley rats age 
from two to only 12 months. 
Exercise and caloric restriction are equally effective in 
preventing the age-related increase in islet volume, 
whereas exercise seems to be more effective in prevent- 
ing the age-related decrease in insulin secretion by iso- 
lated islets from Sprague-Dawley rats, according to 
Reaven and Reaven.21 However, once again it is neces- 
sary to reinterpret the data in a context that more appro- 
priately reflects their utilized protocol for selection of 
islet population. Exercise and caloric restriction reduce 
the contribution by larger islets to the heterogeneous 
size distribution (200 -400 pm diameter) of islets other- 
wise observed in this study as Sprague- Dawley rats age 
from two to 12 months. In fact, tabulated volumes of 
islets that actually were utilized for insulin secretion 
studies are reported to differ significantly only when 
comparing two- and 12-month-old controls. As already 
discussed above, the apparent reduction of insulin re- 
sponsiveness under these conditions is probably the 
consequence of a complex change in distribution of 
functionally distinct islet pop~1ations.l~ 
At the same time, observed rates of glucose-stimu- 
lated insulin secretion by incubated islets from two- 
month-old control, 12-month-old exercised, and 12- 
month-old calorie-restricted rats were probably 
obtained using islet populations of similar, near homo- 
geneity.21 Therefore, it seems appropriate to recalculate 
their data on the basis of the number of islets incubated, 
rather than normalized per islet volume, as published. 
When this is done, the mean rates of insulin secretion in 
response to the highest concentration of glucose used 
are as follows: two-month control (1.79 pU insulin/min 
per 20 islets); 12-month exercised (1.65 pU insulin/min 
per 20 islets); and 12-month calorie-restricted (1.34 pU 
insulin/min per 20 islets). According to their statistical 
analysis, rate of insulin secretion by islets from calorie- 
restricted, but not exercised, 12-month-old rats differ 
significantly from that of two-month-old controls at the 
highest glucose concentration. This probably means 
that exercise is more effective than caloric restriction in 
preventing a modest decrease in the glucose-stimulated 
insulin secretion that characterizes large islets as donor 
rats age from two to only 12 months-perhaps by 
minimizing the obesity that otherwise characterizes the 
Sprague- Dawley rat in this early portion of its lifespan. 
Any impact of exercise or calorie-restriction on the 
much greater loss of capacity for glucose-stimulated in- 
sulin secretion by small islets from 24-month-old donor 
rats13 must await further experimentation of this kind on 
the appropriate islet population from old rats. 
Leiter et alZ2 reported that glucose-stimulated insulin 
secretion by perifused islets in vitro is not impaired as 
male C57B1/6J mice age from five to 25 months. In 
particular, the authors indicated that too little prior ef- 
fort had addressed age-related changes in glucose ho- 
meostasis in specific-pathogen-free (SPF) colonies of 
inbred mice without recognized diabetes or obesity 
genes, such as the C57B1/6J mouse. Consistent with 
their observation is a report by De Clerq et alZ3 that the 
cumulative amount of insulin secreted into the media by 
long-term culture of islets in glucose, as well as their 
subsequent response to glucose-stimulation in an incu- 
bation system, does not diminish as donor age of Wistar 
rats increases from three to 30 months. However, rela- 
tive islet size selected at each donor age before estab- 
lishment of cultures is not indicated. 
Interpretation of the data by Leiter et alZ2 may be 
complicated by the choice of islet populations for at least 
the following three reasons: First and foremost, the se- 
cretory contribution by the population of small (50 - 
80 pm diameter) islets described by Kitahara and Adel- 
man,13 time of onset for which is delayed as donor 
Sprague-Dawley rats age from two to 24 months, is 
apparently not included in the study by Leiter et a1.22 
Furthermore, as indicated in their protocol, medium- 
sized islets isolated and utilized from 25-month-old 
mice were at least 1.5 times larger than those from the 
pancreases of five-month-old mice. Whether or not the 
secretory contribution by some proportion of the 
smaller of those medium-sized islets selected by Leiter et 
alZ2 is progressively impaired in a similar fashion as 
donor rats age is uncertain. Second, the secretory contri- 
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bution by larger islets, prevalence of which increases 
during aging, is progressively enhanced during aging. 
Finally, the increase in islet size observed in this animal 
model during aging is presumably not the consequence 
of obesity. It is tempting to speculate that larger islets do 
not lose insulin responsiveness to glucose in vitro, as the 
donor ages, when the donor is not obese. Such a likeli- 
hood is consistent with the observation by Reaven and 
Reaven2’ that the exercise-induced lessening of obesity 
in Sprague-Dawley rats aged two to 12 months mini- 
mizes the loss of insulin responsiveness in vitro by larger 
islets from older donors, as discussed above. 
Criticism by Burch et alZ4 of earlier research on im- 
pairment of insulin responsiveness to glucose during 
aging by Reaven et a119*25 suggests that apparent deficits 
may be an artifact caused by the more aggressive diges- 
tion needed to free islets from the tougher connective 
tissue of older animals. The former groupz4 appropri- 
ately demonstrated the critical importance of the tech- 
nique utilized for islet isolation to the observed pattern 
of stimulated insulin release. However, their criticism of 
earlier observations on impaired stimulation of insulin 
release during aging is not appropriate for at least the 
following three reasons: 1) Their selection of islet popu- 
lation for perifusion incorrectly masks age differences in 
glucose-stimulated insulin response. In average-sized 
islets, age differences in insulin response are minimized 
because insulin release is impaired to a greater extent in 
smaller i~1ets.l~ 2) Age differences in glucose-stimulated 
insulin response are minimized unnecessarily by the 
selection of 10 and 14 months as old Wistar rats, and 18 
months as old Sprague-Dawley rats.26 3) The authors 
fail to acknowledge previous literature that documents 
the impact of aging on glucose-stimulated insulin re- 
lease by rat i s l e t ~ , * J ~ ~ ~ ’ - ~ ~  as well as the need for method- 
ological precautions in this type of research.30 
Verspohl and Ammon2* reported that isolated islets 
from 24-month-old Wistar rats bind insulin more 
strongly and are more susceptible to feedback inhibition 
of glucose-stimulated insulin secretion in vitro than are 
isolated islets from three-month-old rats. Furthermore, 
the insulin-secreting capacity of 16.7 mmol (300 
mg/100 mL) glucose was the same by incubated islets 
from three- and 24-month-old donor rats when insulin 
secreted into the incubation medium was bound to 
added anti-insulin serum. However, these investigators 
also failed to distinguish between islets of different 
sizes, as discussed above; ie, larger islets are more preva- 
lent in aging rats,13 secrete greater quantities of insulin 
than do smaller islets,13 and contain greater numbers of 
beta cells per islet.19 Whether the impairment of glu- 
cose-stimulated insulin release in vitro by a size- 
matched population of perifused or incubated small 
islets, as donor rats age, can be overcome by addition of 
insulin antibodies to the perifusion or incubation me- 
dium is not known. 
MECHANISM OF ALTERED INSULIN RESPONSE 
Change in Sensitivity to Glucose The mechanism 
that underlies the inability of perifused small islets from 
old rats to secrete insulin in vitro is not understood. 
However, the defect is probably explained in part by a 
decrease in islet sensitivity to glucose. Sartin et aP1 re- 
ported that the sensitivity of perifused small islets to 
glucose in vitro is reduced as fed donor Sprague- 
Dawley rats age from two to 24 months. The threshold 
glucose concentration for insulin response is increased 
from approximately 4 mmol(72 mg/100 mL) to more 
than 8 mmol(l44 mg/100 mL). The maximal secretory 
response is reduced by 33% -50%. At less than maximal 
insulin response, the reduced sensitivity to glucose in 
vitro by small islets from fasted old rats was overcome 
by elevating the concentration of glucose in the perifu- 
sion medium to 27 mmol(500 mg/100 mL). 
Elahi et a r z  used perfused intact pancreas to reveal a 
reduced insulin response to low but not to higher con- 
centrations of glucose as donor Wistar rats aged from 12 
to 23 months. Similar studies of the perfused pancreas 
by Reaven and c o ~ o r k e r s ~ ~ , ~ ~  and by Curry and Mac- 
L a ~ h l a n ~ ~  conflict with one another, but included 
Sprague-Dawley and Fisher-344 rats only as old as 12 
months. In view of the lesser impact of aging on insulin 
secretion by perifused large islets,13 use of the perfused 
intact pancreas32 may result in minimal age differences 
at high glucose concentrations. Furthermore, these data 
suggest that a defect in the regulation of insulin secre- 
tion during aging may be overcome in vivo by the capac- 
ity of old animals to compensate by expanding their 
pool of islet beta ~ e l l s . ~ ~ J ~  
Glucose usage by the islet beta cell may be an obliga- 
tory function in the glucose-stimulated secretion of in- 
~ u l i n . ~ ~  However, data on the impact of aging on islet 
glucose metabolism are conflicting. Reaven and Rea- 
ven3’ reported reduced rates of glucose oxidation to car- 
bon dioxide at glucose concentrations of 16.7 mmol(300 
mg/100 mL), using islet incubation systems from 
Sprague-Dawley rats aged two to only 12 months. In 
disagreement with Reaven and Reaven?’ Burch et al” 
reportedanincreasedrateof 10 mmol(l80mg/lOO mL) 
glucose usage as rate of conversion of 3H-5-~-glucose to 
3H-water, and also observed elevated levels of gluco- 
kinase, phosphofructokinase, and glucose-6-phosphate 
dehydrogenase with perifused average-sized islets from 
fed Wistar and Sprague-Dawley rats aged eight to 18 
months. However, the islet populations isolated from 
older rats by these two sets of investigators are dissimi- 
lar. Using identical methodology to that of Burch et a1 
for assessment of glucose usage,24 Sartin et aP1 reported 
that a slight increase in glucose usage occurs in perifused 
small islets from fed two-month-old Sprague - Dawley 
rats as soon as the glucose concentration is elevated 
above 4 mmol(72 mg/100 mL) and is coincident with 
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biphasic insulin release. In perifused small islets from 
fed 24-month-old rats, glucose usage and insulin release 
do not increase until the glucose concentration is ele- 
vated to 8.35 mmol(150 mg/100 mL).31 However, the 
islet population isolated from older rats by Sartin et a131 
differs from those utilized by Reaven and Reaven3' and 
by Burch et al.24 Ammon et aP8 reported no change in 
glucose usage nor in NADPH or NADH production 
during aging. 
Draznin et a139*40 concluded that the reduction in glu- 
cose-stimulated insulin release in vitro by isolated islets 
from aged rats results from impairment of glucose-in- 
duced margination of secretion vesicles at the plasma 
membrane, whereas lysis of marginated secretion gran- 
ules remains intact as donors age. Insulin secretory re- 
sponse in vitro to a range of glucose concentrations was 
examined using an islet incubation system from two- 
and 18-month-old Fischer-344 rats. The process of se- 
cretion vesicle migration to the plasma membrane was 
assessed by measuring the glucose-stimulated recruit- 
ment of somatostatin receptors during exocytosis. Lysis 
of marginated granules was assessed by sequential peri- 
fusion of islets with varying concentrations of glucose; 
sodium isethionate, and inhibitor of granule lysis; and 
trifluoperazine, an inhibitor of granule margination. 
Once again, values were not obtained in comparable 
islet populations at different ages. As already discussed 
above, the distribution of islet sizes and the insulin-se- 
creting capability by islets of different sizes changes as 
donor rats age.13 Draznin et aP9s40 express their data per 
unit of average islet diameter, as well as per number of 
islets, but fail to consider the possibility that insulin 
responsiveness differs when measured in islets of dif- 
ferent sizes. Furthermore, this study excludes those islet 
populations that are most (40 - 80 pm, diameter) and 
least (350-400 pm, diameter) impaired as donor rats 
age.13 Finally, it is impossible to distinguish between an 
age-related reduction in the magnitude of glucose-in- 
duced somatostatin binding in every islet and binding 
changes that characterize subpopulations of smaller 
and/or larger islets. 
Impaired margination of secretion vesicles at the 
plasma membrane during aging39*40 is a particularly at- 
tractive potential explanation for the delayed initiation 
of glucose-stimulated insulin secretion by small i~1ets.l~ 
The secretory response is at least partially restored when 
small islets from old rats are incubated with glucose and 
antiserum to s~matostatin.~~ However, Draznin et a139,40 
apparently were not aware of the relevant earlier 
1iterature.l3-l8 In any event, it would be extremely use- 
ful to repeat these otherwise elegant studies in perifused 
small islets that are isolated from aging donors. 
Differential Secretion of Stored and Newly Synthe- 
sized Insulin The time course of secretion of newly 
synthesized insulin molecules was examined by Kita- 
hara and Adelman13 using perifusion of small (40- 
80pm, diameter) islets from two- and 24-month-old 
Sprague-Dawley rats with 16.7 mmol (300 
mg/100 mL) glucose and 3H-labeled leucine, and bind- 
ing of insulin secreted into the perifusate to anti-insulin 
serum previously bound to cyanogen bromide-acti- 
vated Sepharose. The time course of the appearance of 
radioactive secretory product bound to insulin antibod- 
ies is identical for islets from each age group. Therefore, 
it was concluded that the secretion of newly synthesized 
insulin molecules by perifused small islets is not im- 
paired as donor rats age. It was suggested further that 
during aging the secretion of newly synthesized insulin 
molecules is preferential to that of previously synthe- 
sized molecules, the mobilization of which for secretion 
apparently is impaired as donor rats age. This preferen- 
tial secretion of newly to previously secreted insulin 
molecules had been reported previously for perfused 
islets from young rats by Sando and G r o d s k ~ . * ~ - ~ ~  
As part of broader investigations of effects of aging on 
insulin synthesis and secretion, Gold et a147 and Wang et 
a148 also observed a decrease in the secretion of newly 
made insulin in vitro by isolated islets from aging donor 
Sprague - Dawley and Fisher-344 rats, as well as prefer- 
ential release of newly made insulin over preformed 
insulin at all ages studied, although earlier published 
reports are acknowledged incorrectly or not at all. One 
potentially serious difficulty in the interpretation of the 
former is the investigators' selection of dissimi- 
lar islet populations from rat donors of increasing age. It 
is not possible to distinguish between changes that are 
attributable to the expression of aging within islets of 
homogeneous size and/or to differential abilities of 
islets of different sizes, since the proportion of larger 
islets increases as donor rats age.13-19 Furthermore, the 
utilized protocol intentionally selects from older donors 
an islet population that contains a greater proportion of 
larger islets than does the islet population selected from 
younger donors. 
Interpretation of the study by Wang et a148 is obfus- 
cated in at least the following ways: 
1) The isolated islets were reported to range in diame- 
ter from 60 to 190 pm, in contrast to reports by others 
who observed both somewhat smaller and much larger 
islets in various rat stocks including the Fisher- 
344.13-'9*39 It is not unlikely that differences in digestion 
technique may account for the limited distribution of 
islet sizes observed.30 
2) The authors indicate that pilot studies revealed no 
differences in insulin secretion between small and large 
islets when results were normalized to amount of islet 
insulin. However, the observed approximately three- 
fold range in islet size is probably also expressed as a 
corresponding threefold range in the amount of beta 
cells and insulin content per i~1et.l~ Therefore, insulin 
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secretion per islet probably increases correspondingly 
with islet size at any given age, as reported previ0us1y.l~ 
3) The authors confirm earlier observations by nu- 
merous others that a greater proportion of larger islets is 
evident in older rats than is evident in younger rats.13-19 
Furthermore, insulin secretion is impaired to a much 
greater extent in small islets than in large islets during 
aging of donor rats.13 Therefore, since a random sam- 
pling of islet sizes was utilized at all tested ages by Wang 
et al,48 it is not possible to distinguish between changes 
that are attributable to the expression of donor rat aging 
within islets of homogeneous size and/or to differential 
abilities of islets of different sizes to secrete insulin. 
4) Finally, the pulse-chase experiments with which 
secretion of newly synthesized and stored insulin was 
investigated were pursued over a four-hour period. The 
extent to which these data were influenced by the more 
prominent feedback inhibition which characterizes 
islets from older rats28 was not investigated. 
Change in Paracrine Control Several observations are 
consistent with the conclusion that changes in the regu- 
lation of glucose-stimulated insulin secretion by isolated 
islets from aging donors are not intrinsic to the islet beta 
cell, but instead may be secondary to alterations in islet 
paracrine control mechanisms that address the quality 
and/or quantity of endogenous glucagon and/or soma- 
tostatin that is available to beta cells within intact islets. 
For example, Molina et alZ7 reported that any defect in 
islet glucose metabolism that interferes with insulin se- 
cretion must occur prior to the metabolism of trioses, 
since glyceraldehyde stimulates insulin secretion simi- 
larly by perifused small islets from fed two- and 13- 
month-old rats. However, their rationale was based on 
the questionable presumption, as discussed above, that 
islet glucose oxidation is diminished during aging. Fur- 
thermore, it remains to be seen whether insulin respon- 
siveness to glyceraldehyde diminishes in rats older than 
13 months. In any event, a more viable interpretation of 
the similar insulin response to glyceraldehyde during 
aging is that the insulin secretory response per se by the 
islet beta cell does not change as rats age. 
Chaudhuri et a141 reported that the impairment of 
glucose-stimulated secretion of insulin during aging is 
overcome partially when small islets from 24-month- 
old, fasted Sprague-Dawley rats are incubated with 
16.7 mmol(300 mg/100 mL) glucose and rabbit serum 
containing antibodies to somatostatin. These results are 
similar to an earlier report of the restoration of impaired 
growth hormone secretion following infusion of old rats 
with antibodies to s~matostatin.~~ However, interpreta- 
tion of the islet data is complicated by a lack of informa- 
tion about the amount of endogenous somatostatin that 
interacts directly with beta cells within intact islets at 
different ages, as well as identification of the particular 
molecular species of rat pancreatic somatostatins0 with 
which the utilized antiserum4' interacts. An additional 
complicating factor is the increased size and adiposity 
that accompany aging in Sprague- Dawley rats under 
the defined environmental  condition^.^^ However, hy- 
persecretion of somatostatin was also reported pre- 
viously for perifused and incubated, isolated islets from 
streptozotocin diabetic, as well as from obese and lean 
age-matched control Zucker rats aged five to 18 
 month^.^^,^^ 
Thus far, changes in glucose-stimulated secretion of 
insulin during aging are not detectable when dispersed 
beta cells are isolated from islets of aging rat donors. 
Magal et aP3 described an insulin secretory response 
that is independent of rat donor age when partially puri- 
fied beta cells from pancreatic islets of three- to 27- 
month-old Sprague - Dawley and Fisher-344 rats are 
incubated with a glucose concentration elevated from 
2.6 mmol (47 mg/100mL) to 16.7 mmol (300 
mg/lOO mL). Physiological integrity of the cell prepara- 
tion was demonstrated by, among other things, sensitiv- 
ity of glucose-stimulated insulin secretion to inhibition 
by somatostatin in an identical fashion at 12 to 27 
months of donor rat age. On the other hand, a poten- 
tially serious difficulty with these data is the small mag- 
nitude of insulin response to glucose relative to that 
observed previously for intact islets both by the same 
lab~ratory'~," and by others.19 However, the low re- 
sponsiveness is also in agreement with the results of 
others who examined dispersed islet ~ e l l s . 5 ~ - ~ ~  The ap- 
parent absence of diminished insulin responsiveness to 
glucose by isolated islet beta cells as donor rats age53 also 
suggests that feedback inhibition of glucose-stimulated 
insulin secretion by insulin from isolated islets of aged 
ratsz9 either requires the integrity of an intact islet archi- 
tecture or is susceptible to damage by the methodology 
utilized for dispersion of islet cells. 
Adenylate Cyclase-CAMP Lipson et alS9 suggested 
that the adenylate cyclase-CAMP system plays a role in 
the impairment of glucose-stimulated insulin release 
during aging. Basal levels of islet adenylate cyclase ac- 
tivity were reduced by 57% as donor Sprague-Dawley 
rats aged from three to 15 months, whereas phospho- 
diesterase and protein kinase activities were unchanged. 
However, basal levels of insulin secretion were identical 
in these two groups of islets. Further difficulties in the 
interpretation of these data include: the failure to mea- 
sure enzyme activities in glucose-stimulated islets in 
which rates of insulin secretion diminish as donor rats 
age; the failure to distinguish between aging, growth, 
and obesity; and the failure to specify islet size. 
CONCLUSIONS 
Research on the regulation of insulin secretion by glu- 
cose during aging has not progressed very far. It seems 
clear that the intact pancreas maintains its ability to 
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secrete insulin rapidly in response to changes in blood 
glucose. However, the manner in which glucose stimu- 
lates insulin secretion apparently differs in young and 
old individuals. The predominant population of pancre- 
atic islets of Langerhans progressively loses its ability to 
respond rapidly to a glucose challenge in vitro as donor 
rats age. At the same time, a morphologically distinct 
population of larger islets becomes more prevalent dur- 
ing aging, apparently accounting for the continued in- 
tegrity of glucose-stimulated insulin response in vivo 
during aging. The mechanism by which the population 
of small islets loses its ability to secrete insulin rapidly in 
response to glucose during aging is unknown, although 
changes in glucose sensitivity and a role of paracrine 
regulation may be of importance. The nature of factors 
that regulate the distribution of heterogeneous islet pop- 
ulations at different ages is unknown. Whether the 
functional decline expressed by the population of small 
islets or the greater prevalence of the population of 
larger islets is of greater fundamental importance to the 
understanding of basic processes of biological aging is 
also unknown. 
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